Moreover, the lens culinaris agglutinin-reactive fraction of AFP (AFP-L3) has emerged as a guideline-endorsed refinement that increases HCC specificity when used alongside total AFP and PIVKA-II, yet its stand-alone sensitivity—especially for early tumors—remains modest and its global adoption uneven [6,7]. Here, AFP is linked to hepatocellular carcinoma.